Target |
Mechanism SCNA blockers [+2] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date28 Dec 1990 |
Mechanism L-type calcium channel blockers [+2] |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Mechanism Potassium channel blockers [+3] |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date01 Aug 2009 |
Sponsor / Collaborator |
Start Date01 Jul 2009 |
Sponsor / Collaborator |
Start Date16 Jun 2009 |
Sponsor / Collaborator- |